Laboratorios Farmaceuticos Rovi, S.A.

ROVI.MC·MCE·Healthcare
Compare
67.85+4.10 (+6.43%)today
As of Nov 5, 1:29 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close63.75
Open65.70
Day range65.7070.15
52-week range53.1086.70
Off day high−3.28%
Off 52-week high−21.74%
Volume400.93K
Avg. volume (3M)93.63K
Market cap3.47B
EPS (TTM)3.62
Forward P/E20.66
P/E ratio (TTM)18.74
Dividend yield1.50% (0.9600)
Beta (5Y)0.29
Shares outstanding51.14M
Short interest—
Earnings dateNov 5, 2026
Analyst target73.69
Profit margin23.96%

Against its peers

Compare in full ›
ROVI.MC AAREYDRUGS.NS HYPE3.SA LP6.F OFSA3.SA 7148.KL
Market cap 3.47B 3.49B 15.26B 2.33B 1.34B 1.11B
P/E (TTM) 18.7 74.4 8.1 11.9 5.7 10.5
Forward P/E 20.7 — 7.1 — 12.0 10.1
Price/book 5.0 2.1 1.0 1.3 1.6 1.4
Dividend yield 1.50% — 4.86% 7.18% 5.18% 3.92%
1-year change +15.91% +10.12% −12.27% −23.98% +10.32% −7.20%
Today +6.43% +0.08% +2.90% +0.77% +1.34% −0.86%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All ROVI.MC news ›

From the 4Search news index, newest first.

In the news

7mentions in 30 days
7with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance